DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Flamm SL, Gane EJ, DuFour JFJ. et al.
Safety of ABT-450/r/Ombitasvir plus Dasabuvir With or Without Ribavirin in HCV-Genotype 1-infected Patients >= 65 Years of Age: Results From Phase 2 and 3 Trials.
Hepatology 2014;
60: 1157a-1158a
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.